Interview: Bill Oldham: CEO Oldham Global
About the Author: HCN News Team
The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Related Posts
Latest News
Glass House Brands Reports Q2 2025 Financial Results
LONG BEACH and TORONTO – Glass House Brands Inc., a leading vertically integrated Cannabis operator in the US, unveiled its second-quarter 2025 financial statements, showing impressive growth in key areas despite ongoing market pressures and ...
Psychedelics Market Set to Reach $22.6 Billion by 2033, Report Finds
NEW YORK – A recent report by Research and Markets reveals the current global psychedelic drugs market is valued at $7.4 billion and is projected to hit $22.6 billion by 2033, exhibiting a substantial compound ...
High Tide Enters German Medical Cannabis Market with Remexian Majority Stake Acquisition
CALGARY – High Tide Inc., a leading Canadian Cannabis retailer, announced its strategic entry into Germany’s medical Cannabis market through a 51% acquisition of Remexian Pharma GmbH, a Frankfurt-based pharmaceutical wholesaler. The deal, valued at ...
